DELAYED RELEASE SOFTGEL CAPSULES
Delayed release softgel capsules including a fill material and a pH dependent shell composition. In one embodiments, the pH dependent shell composition includes gelatin, pectin, dextrose, and from about 0.5 wt % to about 10 wt % of a synthetic polymer. In an alternative embodiment, the pH dependent shell composition includes gelatin, pectin, dextrose, and an organic acid. The delayed release nature of the capsules inhibits premature release of the fill material in acidic pHs (such as pH of from any of about 1.2 to about 6).
1 . A delayed release softgel capsule comprising:
(a) a fill material; and
(b) a pH dependent shell composition,
wherein the fill material comprises at least one active agent, and
wherein the pH dependent shell composition comprises gelatin, pectin, dextrose, and from about 0.5 wt. % to about 10 wt. % of a synthetic polymer, based on total weight of the dry pH dependent shell composition.
2 . The delayed release softgel capsule of claim 1 , wherein the pH dependent shell composition further comprises a plasticizer.
3 . (canceled)
4 . The delayed release softgel capsule of claim 1 , wherein the pectin is selected from the group consisting of amidated pectin, non-amidated pectin and combinations thereof.
5 . The delayed release softgel capsule of claim 1 , wherein the pH dependent shell composition comprises about 40 wt % to about 80 wt % of a gelatin, based on the dry pH dependent shell composition weight.
6 . The delayed release softgel capsule of claim 1 , wherein the pH dependent shell composition comprises about 2 wt % to about 20 wt % of pectin, based on the dry pH dependent shell composition weight.
7 . The delayed release softgel capsule of claim 1 , wherein the pH dependent shell composition comprises about 0.01 wt % to about 4 wt % of dextrose, based on the dry pH dependent shell composition weight.
8 . The delayed release softgel capsule of claim 2 , wherein the pH dependent shell composition comprises about 15 wt % to about 40 wt % of a plasticizer, based on the dry pH dependent shell composition weight.
9 .- 11 . (canceled)
12 . The delayed release softgel capsule of claim 2 , wherein the plasticizer is selected from the group consisting of glycerin, sorbitol and combinations thereof.
13 . (canceled)
14 . The delayed release softgel capsule of claim 1 , wherein the synthetic polymer comprises a methacrylic acid-ethyl acrylate copolymer.
15 . The delayed release softgel capsule of claim 1 ,
wherein the pH dependent shell composition does not dissolve at an acid stage pH of 1.2, 2.0, 3.0, 4.0, 5.0, 6.0, or a sub-range therein, for at least about 15 minutes, at least about 30 minutes, at least about 45 minutes, at least about 60 minutes, at least about 90 minutes, or at least about 120 minutes when measured with a USP Apparatus II with paddles at from about 50 RPM to about 250 RPM, from about 500 ml to about 900 ml 0.1N HCL adjusted to the acid stage pH with phosphate buffer solution, sodium hydroxide solution, or potassium hydroxide solution; and
wherein the pH dependent shell composition dissolves at a buffer pH of above about 6.5, above about 6.8, above about 7.0, above about 7.5, above about 8.0, or above about 8.5 in up to about 60 minutes, up to about 45 minutes, up to about 30 minutes, up to about 15 minutes, or up to about 10 minutes, when measured with a USP Apparatus II with paddles at from about 50 RPM to about 250 RPM, from about 500 ml to about 900 ml phosphate buffer solution, sodium hydroxide solution, or potassium hydroxide solution, adjusted to the buffer pH.
16 . The delayed release softgel capsule of claim 1 ,
wherein the pH dependent shell composition does not disintegrate at an acid stage pH of 1.2, 2.0, 3.0, 4.0, 5.0, 6.0, or a sub-range therein, for at least about 15 minutes, at least about 30 minutes, at least about 45 minutes, at least about 60 minutes, at least about 90 minutes, or at least about 120 minutes when measured with a USP disintegration apparatus from about 500 ml to about 900 ml 0.1N HCL adjusted to the acid stage pH with phosphate buffer solution, sodium hydroxide solution, or potassium hydroxide solution; and
wherein the pH dependent shell composition disintegrated at a buffer pH of above about 6.5, above about 6.8, above about 7.0, above about 7.5, above about 8.0, or above about 8.5 in up to about 60 minutes, up to about 45 minutes, up to about 30 minutes, up to about 15 minutes, or up to about 10 minutes, when measured with a USP disintegration apparatus, from about 500 ml to about 900 ml phosphate buffer solution, sodium hydroxide solution, or potassium hydroxide solution, adjusted to the buffer pH.
17 . (canceled)
18 . (canceled)
19 . A process of preparing a delayed release softgel capsule according to claim 1 comprising:
(a) preparing a fill material comprising an active agent; and
(b) encapsulating the fill material with a pH dependent shell composition.
20 .- 24 . (canceled)
25 . A method for tuning the pH dependent dissolution profile of a delayed release softgel capsule comprised of a fill material encapsulated in a pH dependent shell composition, the method comprising adjusting an amount of pectin and an amount of synthetic polymer in the pH dependent shell composition to attain a target pH dependent dissolution profile in acidic medium and/or in buffer medium.
26 .- 29 . (canceled)
30 . A method of reducing incidence of belching comprising, administering to a subject in need thereof a delayed release softgel capsule according to claim 1 .
31 . (canceled)
32 . (canceled)
33 . A delayed release softgel capsule comprising:
(a) a fill material; and
(b) a pH dependent shell composition,
wherein the fill material comprises at least one active agent, and
wherein the pH dependent shell composition comprises gelatin, pectin, dextrose, and an organic acid.
34 .- 52 . (canceled)
53 . A process of preparing a delayed release softgel capsule according to claim 33 comprising:
(a) preparing a fill material comprising an active agent;
(b) encapsulating the fill material with a pH dependent shell composition.
54 .- 60 . (canceled)
61 . A method for tuning the pH dependent dissolution profile of a delayed release softgel capsule comprised of a fill material encapsulated in a pH dependent shell composition, the method comprising adjusting an amount of pectin and an amount of organic acid in the pH dependent shell composition to attain a target pH dependent dissolution profile in acidic medium and/or in buffer medium.
62 . (canceled)
63 . (canceled)
64 . (canceled)
65 . A method of reducing incidence of belching comprising, administering to a subject in need thereof a delayed release softgel capsule according to claim 33 .
66 . (canceled)
67 . (canceled)
68 . A delayed release softgel capsule comprising:
(a) a fill material; and
(b) a pH dependent shell composition,
wherein the fill material comprises at least one active agent, and
wherein the pH dependent shell composition comprises a film former and from about 0.5 wt. % to about 10 wt. % of a synthetic polymer, based on total weight of the dry pH dependent shell composition.
69 . (canceled)
70 . The delayed release softgel capsules of claim 68 , wherein the film former comprises a non-animal derived gelling agent comprising carrageenan, starch, pregelatinized starch, xanthan gum, agar, pectin, alginate, sugar, high molecular weight polyethylene glycol, sugar derived alcohol, a cellulose derivative, a cellulosic polymer, hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, carboxymethylcellulose, microcrystalline cellulose, attapulgite, bentonite, dextrin, alginate, kaolin, lecithin, magnesium aluminum silicate, carbomer, carbopol, silicon dioxide, curdlan, furcelleran, albumin, soy protein, chitosan, or a combination thereof.
71 .- 74 . (canceled)
75 . A delayed release softgel capsule comprising:
(a) a fill material; and
(b) a pH dependent shell composition,
wherein the fill material comprises at least one active agent, and
wherein the pH dependent shell composition comprises a film former and an organic acid.
76 .- 82 . (canceled)